Program
Fluticasone
Also written as “Fluticasone Propionate”, “Fluticasone propionate” and “Fluticasone Propionate/Formoterol Fumarate”.
Its studies are mostly in Asthma · Pulmonary Disease, Chronic Obstructive · Rhinitis, Allergic, Seasonal · Rhinitis, Allergic · Rhinitis, Allergic, Perennial, led by 24 companies.
Drug pageFluticasone: every studyMany companies study it; this page follows only the 150 they lead. All 340 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| GlaxoSmithKline | 580 open or running | phase 4since Feb 1, 2005 | Feb 1, 2005 | none ahead |
| Respirent Pharmaceuticalsits history only | 182 open or running | phase 3since Sep 17, 2018 | Sep 17, 2018 | none ahead |
| Teva Pharmaceutical Industriesits history only | 140 open or running | phase 4since Dec 11, 2020 | Nov 22, 2011 | none ahead |
| Viatrisits history only | 130 open or running | phase 4since Dec 16, 2016 | Nov 21, 2006 | none ahead |
| Optinose USits history only | 101 open or running | phase 3since Jun 13, 2012 | Jun 13, 2012 | Mar 31, 2028phase 3 · NCT06850805 |
| Mundipharmaits history only | 60 open or running | phase 4since Jun 15, 2015 | Oct 14, 2009 | none ahead |
| SkyePharmaits history only | 50 open or running | phase 3since Oct 27, 2006 | Oct 27, 2006 | none ahead |
| Eurofarma Laboratoriosits history only | 31 open or running | phase 3since Sep 14, 2010 | Sep 14, 2010 | Aug 2028phase 3 · NCT06234345 |
| Merckits history only | 30 open or running | phase 2since Oct 5, 2006 | Oct 5, 2006 | none ahead |
| Hikma Pharmaceuticalsits history only | 20 open or running | no phasesince Jan 5, 2016 | Jan 5, 2016 | none ahead |
| Intech Biopharmits history only | 20 open or running | phase 1since Jun 2, 2015 | Jun 2, 2015 | none ahead |
| Nicox Ophthalmicsits history only | 20 open or running | phase 2since Apr 19, 2019 | Apr 19, 2019 | none ahead |
| Organonits history only | 20 open or running | phase 4since Oct 30, 2008 | Oct 30, 2008 | none ahead |
| Pfizerits history only | 20 open or running | phase 1since Sep 21, 2009 | Sep 21, 2009 | none ahead |
| Ciplaits history only | 10 open or running | phase 3since Dec 26, 2017 | Dec 26, 2017 | none ahead |
| Fougera Pharmaceuticalsits history only | 10 open or running | phase 4since Oct 16, 2007 | Oct 16, 2007 | none ahead |
| Glenmark Pharmaceuticals Ltd. Indiaits history only | 10 open or running | phase 3since May 2, 2022 | May 2, 2022 | none ahead |
| HALEONits history only | 11 open or running | phase 4since Aug 31, 2026 | Aug 31, 2026 | Dec 2026phase 4 · NCT07817134 |
| Kindeva Drug Deliveryits history only | 10 open or running | phase 1since Sep 2, 2014 | Sep 2, 2014 | none ahead |
| Libbs Farmacêutica LTDAits history only | 10 open or running | phase 3since Apr 1, 2020 | Apr 1, 2020 | none ahead |
| Mannkindits history only | 10 open or running | phase 1since May 5, 2008 | May 5, 2008 | none ahead |
| Neotheticsits history only | 10 open or running | phase 2since Oct 16, 2012 | Oct 16, 2012 | none ahead |
| ORAits history only | 10 open or running | phase 4since Sep 19, 2011 | Sep 19, 2011 | none ahead |
| Orion Corporation, Orion Pharmaits history only | 10 open or running | phase 1since Mar 21, 2012 | Mar 21, 2012 | none ahead |
Also a collaborator on its studies: Paratek Pharmaceuticals, Becro, Prolytic, Dynamic Solutions, Parexel, Vectura and PPD DEVELOPMENT, LP.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of GlaxoSmithKline only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 44 studies since Feb 1, 2005.
- Aug 18, 2011Phase 2 study in RhinitisNCT01424397 · 70 enrolled · Austria
- Sep 15, 2011Phase 3 study in AsthmaNCT01435902
- Oct 27, 2011Phase 4 study in AsthmaNCT01462344 · 6,250 enrolled · United States, Argentina, Australia and more
- Nov 17, 2011Phase 4 study in AsthmaNCT01475721 · 11,751 enrolled · United States, Argentina, Australia and more
- Feb 23, 2012Phase 1 study in AsthmaNCT01540708 · 36 enrolled · Australia
- Mar 15, 2012Phase 2 study in AsthmaNCT01563029 · 597 enrolled · United States, Bulgaria, Georgia and more
- Aug 23, 2012Phase 3 study in AsthmaNCT01687283 · 316 enrolled · China
- Sep 6, 2012Phase 3 study in AsthmaNCT01687296 · 261 enrolled · China
- Dec 13, 2012Phase 4 study in Pulmonary Disease, Chronic ObstructiveNCT01751113 · 53 enrolled · Japan
- Mar 21, 2013Phase 3 study in Rhinitis, AllergicNCT01817790 · 626 enrolled · United States
- Jun 27, 2013Phase 4 study in Skin DiseasesNCT01915914 · 107 enrolled · China
- Mar 20, 2014Phase 3 study in AsthmaNCT02094937 · 430 enrolled · Japan
- Nov 24, 2014Phase 3 study in AsthmaNCT02301975 · 1,526 enrolled · United States, Argentina, Brazil and more
- Mar 24, 2016Phase 4 study in AsthmaNCT02730351 · 75 enrolled · United States, Canada
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 58 GlaxoSmithKline leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT02730351Asthma · United States, Canada | 4 | Completed | Feb 3, 2017 | 75 |
| NCT02301975Asthma · United States, Argentina, Brazil and more | 3 | Completed | Nov 1, 2016 | 1,526 |
| NCT02094937Asthma · Japan | 3 | Completed | Aug 28, 2015 | 430 |
| NCT01915914Skin Diseases · China | 4 | Completed | Feb 15, 2015 | 107 |
| NCT01817790Rhinitis, Allergic · United States | 3 | Completed | Feb 2013 | 626 |
| NCT01751113Pulmonary Disease, Chronic Obstructive · Japan | 4 | Completed | Nov 2013 | 53 |
| NCT01687296Asthma · China | 3 | Completed | Jun 1, 2013 | 261 |
| NCT01687283Asthma · China | 3 | Completed | Nov 7, 2013 | 316 |
| NCT01563029Asthma · United States, Bulgaria, Georgia and more | 2 | Completed | Sep 24, 2014 | 597 |
| NCT01540708Asthma · Australia | 1 | Completed | Sep 4, 2012 | 36 |
| NCT01475721Asthma · United States, Argentina, Australia and more | 4 | Completed | Jun 23, 2015 | 11,751 |
| NCT01462344Asthma · United States, Argentina, Australia and more | 4 | Completed | Nov 1, 2015 | 6,250 |
| NCT01435902Asthma | 3 | Withdrawn | Aug 2012 | 0 |
| NCT01424397Rhinitis · Austria | 2 | Completed | Jul 7, 2011 | 70 |
| NCT01192178Asthma · United States | 4 | Completed | Dec 2010 | 339 |
| NCT01156792Asthma · United States | 2 | Completed | Oct 2011 | 162 |
| NCT01124422Pulmonary Disease, Chronic Obstructive · United States, Canada | 4 | Completed | May 1, 2011 | 255 |
| NCT00984659Pulmonary Disease, Chronic Obstructive · United States | 4 | Completed | Jul 1, 2010 | 366 |
| NCT00848965Rhinitis, Allergic, Perennial · Austria | 4 | Completed | Jan 2008 | 59 |
| NCT00784550Pulmonary Disease, Chronic Obstructive · United States | 4 | Completed | Dec 2009 | 342 |
| NCT00633217Pulmonary Disease, Chronic Obstructive · United States | 4 | Completed | Feb 2009 | 247 |
| NCT00612820Rhinitis, Allergic, Seasonal · Austria | 2 | Completed | May 2008 | 55 |
| NCT00539006Rhinitis, Allergic, Perennial · United States | 4 | Completed | Nov 2007 | 377 |
| NCT00519636Rhinitis, Allergic, Perennial · United States | 4 | Completed | Nov 2007 | 360 |
| NCT00517634Asthma · United States, United Kingdom | 4 | Completed | Jul 2008 | 23 |
| NCT00503009Asthma · United States | 4 | Terminated | Jul 2008 | 16 |
| NCT00480649Asthma · Korea, Republic of | 4 | Completed | Sep 2005 | 424 |
| NCT00456313Asthma · Netherlands | 4 | Withdrawn | Dec 2007 | 0 |
| NCT00455923Asthma · Sweden | 4 | Completed | Jul 31, 2007 | 100 |
| NCT00453778Asthma | 4 | Completed | May 2004 | 14 |
| NCT00452699Asthma · United States, Argentina, Brazil and more | 4 | Completed | May 2009 | 621 |
| NCT00452348Asthma · United States, Argentina, Brazil and more | 4 | Completed | Apr 2009 | 628 |
| NCT00448435Asthma · Japan | 3 | Completed | Jan 2008 | 51 |
| NCT00441441Asthma · United States, Australia, Canada and more | 3 | Completed | Jan 2008 | 351 |
| NCT00400855Asthma · New Zealand | 2 | Completed | Aug 2005 | 49 |
| NCT00398476Rhinitis, Allergic, Perennial · United States | 3 | Completed | Dec 4, 2006 | 127 |
| NCT00370591Asthma · United Kingdom | 4 | Completed | Apr 2004 | 48 |
| NCT00370097Asthma · United States | 1 | Completed | Apr 12, 2007 | 16 |
| NCT00369993Asthma · New Zealand | 2 | Completed | May 2005 | 20 |
| NCT00364442Asthma · Germany | 1 | Completed | Apr 13, 2005 | 12 |
| NCT00363480Asthma · Germany | 4 | Completed | Sep 1, 2007 | 221 |
| NCT00358358Pulmonary Disease, Chronic Obstructive · United States, Chile, Estonia and more | 4 | Completed | Feb 2007 | 163 |
| NCT00353873Asthma · Belgium, Denmark, France and more | 4 | Completed | Oct 26, 2006 | 506 |
| NCT00351143Asthma · Denmark, Switzerland | 4 | Completed | Jun 13, 2007 | 274 |
| NCT00348361Rhinitis, Allergic · Netherlands, United Kingdom | 1 | Completed | 48 | |
| NCT00315744Asthma · Germany | 4 | Completed | Apr 12, 2007 | 285 |
| NCT00296530Asthma · United States | 4 | Completed | Jul 2007 | 600 |
| NCT00296491Asthma · United States, Canada, Estonia and more | 4 | Completed | Oct 2007 | 725 |
| NCT00291382Asthma · Belgium, Estonia, Finland and more | 4 | Completed | Jul 2007 | 150 |
| NCT00273026Asthma · Canada | 4 | Terminated | 680 | |
| NCT00269087Pulmonary Disease, Chronic Obstructive · Japan | 3 | Completed | Oct 1, 2006 | 122 |
| NCT00169546Asthma · New Zealand, United Kingdom | 4 | Completed | Dec 2005 | 64 |
| NCT00158834Asthma · Netherlands | 3 | Completed | 200 | |
| NCT00118716Bronchial Spasm · United States | 4 | Completed | Apr 1, 2006 | 248 |
| NCT00118690Bronchial Spasm · United States | 4 | Completed | Dec 2005 | 227 |
| NCT00115492Pulmonary Disease, Chronic Obstructive · United States, Canada | 4 | Completed | Jun 2007 | 797 |
| NCT00102882Asthma · United States, Kenya, Peru and more | 4 | Completed | Jan 2007 | 547 |
| NCT00102765Asthma · United States | 4 | Completed | Apr 2007 | 479 |
How it is read
Names in the registry
- “Fluticasone Propionate”, 17 entries
- “Fluticasone propionate”, 13 entries
- “Fluticasone Propionate/Formoterol Fumarate”, 9 entries
- “fluticasone propionate”, 7 entries
- “fluticasone propionate/salmeterol”, 7 entries
Codes read as this program: NCX4251, FP100.
Conditions, from the studies’ own filings
- Asthma, 84 studies
- Pulmonary Disease, Chronic Obstructive, 18 studies
- Rhinitis, Allergic, Seasonal, 11 studies
- Rhinitis, Allergic, 9 studies
- Rhinitis, Allergic, Perennial, 6 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.